MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its position in CME Group Inc. (NASDAQ:CME - Free Report) by 5.9% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 64,586 shares of the financial services provider's stock after purchasing an additional 3,618 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.'s holdings in CME Group were worth $14,999,000 at the end of the most recent reporting period.
A number of other institutional investors have also added to or reduced their stakes in CME. Moore Capital Management LP grew its stake in shares of CME Group by 3.6% in the 4th quarter. Moore Capital Management LP now owns 46,606 shares of the financial services provider's stock worth $10,823,000 after buying an additional 1,606 shares during the last quarter. Lighthouse Investment Partners LLC bought a new stake in CME Group in the fourth quarter worth $551,000. Investment Management Corp of Ontario grew its stake in shares of CME Group by 32.5% in the fourth quarter. Investment Management Corp of Ontario now owns 15,794 shares of the financial services provider's stock worth $3,668,000 after acquiring an additional 3,870 shares during the last quarter. Jacobs Levy Equity Management Inc. bought a new position in shares of CME Group during the fourth quarter valued at $9,553,000. Finally, Janus Henderson Group PLC increased its holdings in shares of CME Group by 24.7% during the fourth quarter. Janus Henderson Group PLC now owns 3,135,753 shares of the financial services provider's stock valued at $728,260,000 after acquiring an additional 621,713 shares in the last quarter. Institutional investors own 87.75% of the company's stock.
CME Group Stock Performance
CME stock traded up $1.65 during midday trading on Monday, reaching $277.94. 1,617,773 shares of the company's stock traded hands, compared to its average volume of 2,179,403. The company has a current ratio of 1.01, a quick ratio of 1.02 and a debt-to-equity ratio of 0.10. CME Group Inc. has a 52-week low of $190.70 and a 52-week high of $286.48. The stock has a market cap of $100.16 billion, a P/E ratio of 28.74, a PEG ratio of 6.76 and a beta of 0.45. The stock's 50-day moving average is $265.86 and its 200 day moving average is $247.33.
CME Group (NASDAQ:CME - Get Free Report) last issued its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm had revenue of $1.64 billion during the quarter, compared to the consensus estimate of $1.56 billion. During the same quarter in the previous year, the firm posted $2.50 EPS. The company's revenue for the quarter was up 10.4% compared to the same quarter last year. As a group, analysts anticipate that CME Group Inc. will post 10.49 EPS for the current year.
CME Group Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, June 25th. Shareholders of record on Monday, June 9th will be given a $1.25 dividend. This represents a $5.00 dividend on an annualized basis and a yield of 1.80%. The ex-dividend date of this dividend is Monday, June 9th. CME Group's payout ratio is 50.30%.
Insiders Place Their Bets
In other news, insider Derek Sammann sold 4,650 shares of the business's stock in a transaction dated Monday, May 5th. The stock was sold at an average price of $280.61, for a total value of $1,304,836.50. Following the transaction, the insider now directly owns 8,336 shares in the company, valued at $2,339,164.96. The trade was a 35.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Charles P. Carey sold 3,000 shares of the company's stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $272.56, for a total value of $817,680.00. Following the completion of the transaction, the director now directly owns 5,400 shares of the company's stock, valued at approximately $1,471,824. This trade represents a 35.71% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 26,434 shares of company stock worth $6,987,065 over the last quarter. 0.30% of the stock is currently owned by corporate insiders.
Analyst Ratings Changes
Several analysts recently commented on the stock. Raymond James raised shares of CME Group from a "market perform" rating to an "outperform" rating and set a $287.00 price objective on the stock in a research report on Monday, March 10th. Morgan Stanley increased their price target on shares of CME Group from $301.00 to $304.00 and gave the company an "overweight" rating in a report on Thursday, April 24th. Bank of America boosted their price objective on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a report on Wednesday, April 2nd. Barclays increased their target price on CME Group from $279.00 to $283.00 and gave the company an "equal weight" rating in a research note on Wednesday, April 23rd. Finally, Royal Bank of Canada reissued a "sector perform" rating and issued a $269.00 target price on shares of CME Group in a report on Thursday, April 3rd. Three investment analysts have rated the stock with a sell rating, seven have assigned a hold rating, five have issued a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $256.80.
Read Our Latest Research Report on CME Group
CME Group Profile
(
Free Report)
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
See Also
Before you consider CME Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CME Group wasn't on the list.
While CME Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
